World's Best Scientists 2026 revealed!
S. J. H. Van Deventer

S. J. H. Van Deventer

D-Index & Metrics

Immunology

D-Index
117
Citations
50114
World Ranking
365
National Ranking
12

Medicine

D-Index
120
Citations
55470
World Ranking
3738
National Ranking
145

S. J. H. Van Deventer publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where S. J. H. Van Deventer sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 419 publications — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

S. J. H. Van Deventer D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where S. J. H. Van Deventer sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 117 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

S. J. H. Van Deventer is affiliated with Leiden University in the Netherlands. Their research primarily focuses on medicine, with specific expertise in surgery and emergency medicine as subfields. The scientist's work addresses several main topics within these areas.

The research themes prominently include:

  • HIV-related health complications and treatments
  • Lipoproteins and cardiovascular health
  • Kawasaki disease and coronary complications

Among recent scholarly contributions, Van Deventer has published a paper titled Longitudinal Assessment of Lipoprotein(a) Levels in Perinatally HIV-Infected Children and Adolescents in 2021. This paper appeared in the journal Viruses.

Van Deventer frequently collaborates with several co-authors in their research endeavors. These include:

  • Jason G. van Genderen
  • Malon Van den Hof
  • Claudia G. de Boer
  • Hans Jansen
  • Sotirios Tsimikas

The scientist's publications are found predominantly in the journal Viruses, reflecting a focus on infectious diseases and related medical research.

Best Publications

  • A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

    S. R. Targan;S. B. Hanauer;S. J. H. Van Deventer;L. Mayer

  • Infliximab for the treatment of fistulas in patients with Crohn's disease.

    D.H. Present;P.J. Rutgeerts;S.R. Targan;S.B. Hanauer

  • Polyp miss rate determined by tandem colonoscopy: a systematic review.

    Jeroen C van Rijn;Johannes B Reitsma;Jaap Stoker;Patrick M Bossuyt

  • Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

    Geert D'Haens;Filip Baert;Gert van Assche;Philip Caenepeel

  • Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

    H. M. Van Dullemen;S. J. H. Van Deventer;D. W. Hommes;H. A. Bijl

  • Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways

    S. J. H. Van Deventer;H. R. Buller;J. W. Ten Cate;L. A. Aarden

  • A Phase I Trial With Transgenic Bacteria Expressing Interleukin-10 in Crohn’s Disease

    Henri Braat;Pieter Rottiers;Daniel W. Hommes;Nathalie Huyghebaert

  • Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial.

    Geert D'Haens;S Van Deventer;R Van Hogezand;D Chalmers

  • Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn’s disease

    Jan M.H Van den Brande;Henri Braat;Gijs R van den Brink;Henri H Versteeg

  • Activation of coagulation after administration of tumor necrosis factor to normal subjects.

    T van der Poll;H R Büller;H ten Cate;C H Wortel

  • Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

    T ten Hove;C van Montfrans;M P Peppelenbosch;S J H van Deventer

  • Tumour necrosis factor and Crohn's disease.

    S.J.H. van Deventer

  • Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets

    D W Hommes;M P Peppelenbosch;S J H van Deventer

  • Short chain fatty acids stimulate epithelial mucin 2 expression through differential effects on prostaglandin E(1) and E(2) production by intestinal myofibroblasts.

    L E M Willemsen;M A Koetsier;S J H van Deventer;E A F van Tol

  • Inhibition of stress-activated MAP kinases induces clinical improvement in moderate to severe Crohn's disease

    Daan Hommes;Bernt van den Blink;Terry Plasse;Joep Bartelsman

  • Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

    M Levi;H ten Cate;K A Bauer;T van der Poll

  • Multiple doses of intravenous interleukin 10 in steroid-refractory Crohn's disease. Crohn's Disease Study Group.

    S.J.H. van Deventer;C.O. Elson;R.N. Fedorak

  • Pathogenesis of disseminated intravascular coagulation in sepsis

    M. Levi;H. Ten Cate;T. Van Der Poll;S. J. H. Van Deventer

  • Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

    T van der Poll;M Levi;C E Hack;H ten Cate

  • Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia.

    D. Pajkrt;J. E. Doran;F. Koster;P. G. Lerch

  • Leptin is a growth factor for colonic epithelial cells.

    James C.H. Hardwick;Gijs R. Van Den Brink;G.J. Offerhaus;Sander J.H. Van Deventer

Frequent Co-Authors

J. W. Ten Cate
J. W. Ten Cate University of Amsterdam
G. N. J. Tytgat
G. N. J. Tytgat University of Amsterdam
Maikel P. Peppelenbosch
Maikel P. Peppelenbosch Erasmus University Rotterdam
Marcel Levi
Marcel Levi University of Amsterdam
Stefan Schreiber
Stefan Schreiber Kiel University
Jan M. Prins
Jan M. Prins University of Amsterdam
Pieter H. Reitsma
Pieter H. Reitsma Leiden University
Brian G. Feagan
Brian G. Feagan University of Western Ontario
Dirk J. Gouma
Dirk J. Gouma University of Amsterdam

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals transition into advanced nursing roles, which provide specialized knowledge crucial for immunology-related patient care. Exploring an fnp to acnp bridge program online can be an excellent way for Family Nurse Practitioners to expand their expertise towards acute care settings.

Accelerated pathways exist as well, ensuring faster entry into advanced practice roles. Programs like the accelerated nurse practitioner program help qualified candidates achieve nurse practitioner status efficiently, blending rigorous academics with flexible online learning.

For those coming from non-nursing backgrounds but aspiring to enter healthcare, high-quality options such as online rn programs for non nurses offer foundational nursing education while accommodating busy schedules.

Understanding potential earnings is also critical when planning a career. Referencing the doctor of nursing practice salary data can clarify income expectations across states for advanced practitioners with a DNP degree. Together, these pathways support diverse careers aligned with Immunology and healthcare advancement.

Best Scientists Citing S. J. H. Van Deventer

Trending Scientists

Recently Published Articles